RT Journal Article
SR Electronic
T1 Endotoxemia and circulating bacteriome in severe COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.29.20109785
DO 10.1101/2020.05.29.20109785
A1 Sirivongrangson, Phatadon
A1 Kulvichit, Win
A1 Payungporn, Sunchai
A1 Pisitkun, Trairak
A1 Chindamporn, Ariya
A1 Peerapornratana, Sadudee
A1 Pisitkun, Prapaporn
A1 Chitcharoen, Suwalak
A1 Sawaswong, Vorthon
A1 Worasilchai, Navaporn
A1 Kampunya, Sarinya
A1 Putcharoen, Opass
A1 Thawitsri, Thammasak
A1 Leelayuwatanakul, Nophol
A1 Kongpolprom, Napplika
A1 Phoophiboon, Vorakamol
A1 Sriprasart, Thitiwat
A1 Samransamruajkit, Rujipat
A1 Tungsanga, Somkanya
A1 Tiankanon, Kanitha
A1 Lumlertgul, Nuttha
A1 Leelahavanichkul, Asada
A1 Sriphojanart, Tueboon
A1 Tantawichien, Terapong
A1 Thisyakorn, Usa
A1 Chirathaworn, Chintana
A1 Praditpornsilpa, Kearkiat
A1 Tungsanga, Kriang
A1 Eiam-Ong, Somchai
A1 Sitprija, Visith
A1 Kellum, John A.
A1 Srisawat, Nattachai
YR 2020
UL http://medrxiv.org/content/early/2020/06/02/2020.05.29.20109785.abstract
AB Purpose When severe, COVID-19 shares many clinical features with bacterial sepsis. Yet, secondary bacterial infection is uncommon. However, as epithelium are injured and barrier function is lost, bacterial products entering the circulation might contribute to the pathophysiology of COVID-19.Methods We studied 19 adults, severely ill patients with COVID-19 infection, who were admitted to King Chulalongkorn Memorial Hospital, Bangkok, Thailand, between 13th March and 17th April 2020. Blood samples on day 1, 3, and 7 of enrollment were analyzed for endotoxin activity assay (EAA), (1→3)-β-D-Glucan (BG), and 16S rRNA gene sequencing to determine the circulating bacteriome.Results Of the 19 patients, 14 were in intensive care and 10 patients received mechanical ventilation. We found 8 patients with high EAA (≥ 0.6) and about half of the patients had high serum BG levels which tended to be higher in later in the illness. Although only 1 patient had a positive blood culture, 18 of 19 patients were positive for 16S rRNA gene amplification. Proteobacteria was the most abundant phylum. The diversity of bacterial genera was decreased overtime.Conclusions Bacterial DNA and toxins were discovered in virtual all severely ill COVID-19 pneumonia patients. This raises a previously unrecognized concern for significant contribution of bacterial products in the pathogenesis of this diseaseCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialTCTR20200527001Funding StatementThe investigator-initiated study was funded by the Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by Faculty of Medicine, Chulalongkorn University ethics committee (IRB no. 336/63). The informed consent was waived due to the observational nature of the study. The study was designed and conducted according to the STROBE guideline.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are not publicly available.